Poles and Hungarians are taking legal action against banks that sold them foreign exchange mortgages, saying they were offered poor financial advice

Coalition negotiators propose removal of exemptions that have shielded companies from the cost of moving to renewable power

London-listed pharmaceuticals group says the deal will boost its rare disease unit and generate cost synergies of about $150m by 2015